Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.
Li
F P
FP
Dana-Farber Cancer Institute, Boston, Mass.
Garber
J E
JE
Friend
S H
SH
Strong
L C
LC
Patenaude
A F
AF
Juengst
E T
ET
Reilly
P R
PR
Correa
P
P
Fraumeni
J F
JF
D026724:Ethical Review; D016158:Genes, p53; D030342:Genetic Diseases, Inborn; D006801:Humans; D016864:Li-Fraumeni Syndrome / Q000235:genetics*; D033242:Minors; D009154:Mutation; D009369:Neoplasms / Q000209:etiology / Q000235:genetics*; D033282:Parental Consent; D010865:Pilot Projects; D018570:Risk Assessment